| pubmed-article:8106027 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8106027 | lifeskim:mentions | umls-concept:C0019693 | lld:lifeskim |
| pubmed-article:8106027 | lifeskim:mentions | umls-concept:C0155765 | lld:lifeskim |
| pubmed-article:8106027 | lifeskim:mentions | umls-concept:C0035331 | lld:lifeskim |
| pubmed-article:8106027 | lifeskim:mentions | umls-concept:C0162492 | lld:lifeskim |
| pubmed-article:8106027 | lifeskim:mentions | umls-concept:C0205470 | lld:lifeskim |
| pubmed-article:8106027 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:8106027 | pubmed:dateCreated | 1993-12-21 | lld:pubmed |
| pubmed-article:8106027 | pubmed:abstractText | The relationship between retinal microangiopathy and some features of human immunodeficiency virus (HIV) infection such as HIV antigenemia, antibodies to the viral proteins, T lymphocyte subsets, were studied in 71 patients with acquired immunodeficiency syndrome (AIDS). The absence of antibodies to the HIV p24 protein was significantly related to retinal microangiopathy (p = 0.0051) and more closely to retinal cotton-wool spots (p = 0.0007); the combination of positive antigenemia with the absence of antibodies to p24, which is typical of the later phases of HIV infection, was found in a larger percentage of patients with cotton-wool spots (p = 0.0013) than in subjects with every sign of microangiopathy (p = 0.0546). T-helper (CD4+) cells count below 200 cells/mm3 was also detected in a higher percentage of patients with HIV-related retinal microangiopathy (p = 0.009). These findings suggest that retinal microangiopathy and especially retinal cotton-wool spots are related to the progression of immunodeficiency. | lld:pubmed |
| pubmed-article:8106027 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8106027 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8106027 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8106027 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8106027 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8106027 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8106027 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8106027 | pubmed:issn | 1120-6721 | lld:pubmed |
| pubmed-article:8106027 | pubmed:author | pubmed-author:AiutiFF | lld:pubmed |
| pubmed-article:8106027 | pubmed:author | pubmed-author:SoriceFF | lld:pubmed |
| pubmed-article:8106027 | pubmed:author | pubmed-author:Pivetti-Pezzi... | lld:pubmed |
| pubmed-article:8106027 | pubmed:author | pubmed-author:VulloVV | lld:pubmed |
| pubmed-article:8106027 | pubmed:author | pubmed-author:MezzaromaII | lld:pubmed |
| pubmed-article:8106027 | pubmed:author | pubmed-author:AccorintiMM | lld:pubmed |
| pubmed-article:8106027 | pubmed:author | pubmed-author:TamburiSS | lld:pubmed |
| pubmed-article:8106027 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8106027 | pubmed:volume | 3 | lld:pubmed |
| pubmed-article:8106027 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8106027 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8106027 | pubmed:pagination | 138-42 | lld:pubmed |
| pubmed-article:8106027 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8106027 | pubmed:meshHeading | pubmed-meshheading:8106027-... | lld:pubmed |
| pubmed-article:8106027 | pubmed:meshHeading | pubmed-meshheading:8106027-... | lld:pubmed |
| pubmed-article:8106027 | pubmed:meshHeading | pubmed-meshheading:8106027-... | lld:pubmed |
| pubmed-article:8106027 | pubmed:meshHeading | pubmed-meshheading:8106027-... | lld:pubmed |
| pubmed-article:8106027 | pubmed:meshHeading | pubmed-meshheading:8106027-... | lld:pubmed |
| pubmed-article:8106027 | pubmed:meshHeading | pubmed-meshheading:8106027-... | lld:pubmed |
| pubmed-article:8106027 | pubmed:meshHeading | pubmed-meshheading:8106027-... | lld:pubmed |
| pubmed-article:8106027 | pubmed:meshHeading | pubmed-meshheading:8106027-... | lld:pubmed |
| pubmed-article:8106027 | pubmed:meshHeading | pubmed-meshheading:8106027-... | lld:pubmed |
| pubmed-article:8106027 | pubmed:meshHeading | pubmed-meshheading:8106027-... | lld:pubmed |
| pubmed-article:8106027 | pubmed:meshHeading | pubmed-meshheading:8106027-... | lld:pubmed |
| pubmed-article:8106027 | pubmed:meshHeading | pubmed-meshheading:8106027-... | lld:pubmed |
| pubmed-article:8106027 | pubmed:meshHeading | pubmed-meshheading:8106027-... | lld:pubmed |
| pubmed-article:8106027 | pubmed:meshHeading | pubmed-meshheading:8106027-... | lld:pubmed |
| pubmed-article:8106027 | pubmed:meshHeading | pubmed-meshheading:8106027-... | lld:pubmed |
| pubmed-article:8106027 | pubmed:articleTitle | Immunological and viral markers of HIV infection and retinal microangiopathy. | lld:pubmed |
| pubmed-article:8106027 | pubmed:affiliation | Institute of Ophthalmology, University of Roma La Sapienza, Italy. | lld:pubmed |
| pubmed-article:8106027 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8106027 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
